Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Crit Care Med. 2020 Feb;48(2):200–209. doi: 10.1097/CCM.0000000000004132

Table 1.

Demographic Characteristics and Outcomes of 16,124 Subjects who met SIRS-first or SOFA-first

Variable SIRS-first n=9,087 SOFA-first n=7,037 p-value
Age at presentation (median, interquartile range) 59 (44, 73) 65 (54, 79) <0.0001
Female 4,352 (47.9) 3,257 (46.3) 0.042
Race 0.006
White 4,077 (44.9) 3,310 (47.0)
Asian 2,131 (23.5) 1,507 (21.4)
Black 1,640 (18.1) 1,296 (18.4)
Other 1,239 (13.6) 924 (13.1)
Payer type <0.0001
 Medicare 4,325 (47.6) 4,274 (60.7)
 Medi-Cal 2,324 (25.6) 1,505 (21.4)
 Commercial 2,232 (24.6) 1,160 (16.5)
 Other/Self-Pay 206 (2.3) 98 (1.4)
Chronic renal failurea 1,512 (16.6) 2,067 (29.4) <0.0001
Chronic liver diseasea 942 (10.4) 1,280 (18.2) <0.0001
Cancera
 Lymphoma 326 (3.6) 210 (3.0) 0.034
 Solid tumor 963 (10.6) 741 (10.5) 0.890
 Metastatic cancer 948 (10.4) 617 (8.8) <0.0001
van Walraven Comorbidity Index value (median, interquartile range) 7 (0, 15) 10 (4, 17) <0.0001
Admission level of care <0.0001
 Discharged from ED 420 (4.6) 189 (2.7)
 Admission to outside facility 129 (1.4) 72 (1.0)
 Acute care 4,930 (54.3) 4,386 (62.3)
 Stepdown care 2,225 (24.5) 1,426 (20.3)
 Intensive care 1,383 (15.2) 964 (13.7)
Year of ED encounterb 0.359
 2012 964 (10.6) 694 (9.9)
 2013 1,936 (21.3) 1,449 (20.6)
 2014 1,952 (21.5) 1,541 (21.9)
 2015 2,164 (23.8) 1,718 (24.4)
 2016 2,071 (22.8) 1,635 (23.2)
Time to antibiotics in hours (median, interquartile range) 2.7 (1.5, 4.9) 4.1 (2.3, 7.9) <0.0001
Positive blood culture 564 (6.2) 309 (4.4) <0.0001
Receipt of validated sepsis discharge codec 3,383 (37.2) 1,621 (23.0) <0.0001
Site of infection coded on discharge <0.0001
 None coded 3,128 (34.4) 2,660 (37.8)
 Skin and soft tissue infection 592 (6.5) 563 (8.0)
 Urinary tract infection 523 (5.8) 683 (9.7)
 Pneumonia 1,237 (13.6) 863 (12.3)
 Bacteremia 837 (9.2) 437 (6.2)
 Sepsis 412 (4.5) 208 (3.0)
 Otherd 408 (4.5) 426 (6.1)
 Multiple sites 1,950 (21.5) 1,197 (17.0)
In-hospital mortality 579 (6.4) 479 (6.8) 0.268
ICU length of stay among survivors (median, interquartile range)e 2.8 (1.7,5.1) 3.0 (1.8,5.1) 0.138
Vasopressor receipt 675 (7.4) 560 (8.0) 0.210
Receipt of mechanical ventilation 741 (8.2) 606 (8.6) 0.302
a

Defined using the Elixhauser comorbidity ICD-9/10 grouping method

b

Study period was June 1, 2012-December 31, 2016

c

Codes included ICD-10: A02.1, A22.7, A26.7, A32.7, A40.0, A40.1, A40.3, A40.8, A40.9, A41.01, A41.02, A41.1, A41.2, A41.3, A41.4, A41.50, A41.51, A41.52, A41.53, A41.59, A41.81, A41.89, A41.9, A42.7, A54.86, B37.7, R65.20, R65.2; ICD-9: 038.0, 038.1, 038.11, 038.12, 038.19, 038.2, 038.3, 038.4, 038.41, 038.42, 038.43, 038.44, 038.49, 038.8, 038.9, 995.91, 995.92.

d

Other sites included osteomyelitis, meningitis, peritonitis, Clostridium difficile infection, biliary infection, and device related infection

e

There were 1,636 SIRS-first and 1,209 SOFA-first patients who survived and were ever admitted to the ICU.